Shares of AdaptHealth Corp. (NASDAQ: AHCO) plummeted 16.45% in pre-market trading on Monday, after the healthcare services company reported mixed third-quarter results and lowered its full-year revenue guidance.
For the third quarter, AdaptHealth posted earnings of $0.40 per share, surpassing analysts' estimates of $0.17 per share. However, the company's revenue of $805.9 million fell short of expectations, missing the consensus estimate of $809.3 million.
More concerning for investors, AdaptHealth slashed its fiscal 2024 revenue guidance to a range of $3.22 billion to $3.26 billion, down from its previous forecast of $3.26 billion to $3.32 billion. The lowered guidance overshadowed the company's better-than-expected earnings, leading to a sharp sell-off in the stock.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。